SCHEMBL6493573

SCHEMBL6493573

Nc1ccc2[nH]c(-c3cc(Cl)c(N)c(Cl)c3)nc2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.78
MAPT P10636 12/20 0.78
SMN1; SMN2 Q16637 10/20 0.78
MEN1 O00255 10/20 0.78
KMT2A Q03164 10/20 0.78
HPGD P15428 10/20 0.78
GAA P10253 9/20 0.78
NPC1 O15118 9/20 0.78
RAB9A P51151 9/20 0.78
TP53 P04637 6/20 0.78
POLB P06746 6/20 0.78
BLM P54132 4/20 0.78
HTT P42858 3/20 0.78
KDM4E B2RXH2 10/20 0.57
USP2 O75604 4/20 0.57
TDP1 Q9NUW8 3/20 0.57
CACNA1B Q00975 3/20 0.57
APBA1 Q02410 3/20 0.57
THRB P10828 2/20 0.57
LMNA P02545 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493579 0.88 MAPT (1.00) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL3205888 0.86 ALDH1A1 (0.63) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL6483416 0.85 ALDH1A1 (0.79) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1655753 0.83 MEN1 (0.73) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL30533210 0.83 MEN1 (0.73) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL2246334 0.83 ALDH1A1 (0.77) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL31289468 0.82 ALDH1A1 (0.59) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL8769051 0.82 MEN1 (0.71) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL30307784 0.82 ALDH1A1 (0.74) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL159873 0.82 ALDH1A1 (0.74) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP ALDH1A1 1577/4885MAPT 7/4885SMN1; SMN2 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.